Dr Timothy E Simpson, MD | |
920 Main Street, Hackensack, NJ 07480 | |
(201) 342-7733 | |
(201) 342-7998 |
Full Name | Dr Timothy E Simpson |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 36 Years |
Location | 920 Main Street, Hackensack, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255469904 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 25MA06213300 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hackensack University Medical Center | Hackensack, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hackensack Meridian Health Medical Group - Specialty Care Pc | 9133032519 | 1090 |
News Archive
As the coronavirus pandemic claims lives and overwhelms health care systems throughout the world, scientists are closely watching several late-stage trials of the antiviral drug remdesivir.
BIOCIUS Life Sciences Inc., developers of the RapidFire® high-throughput mass spectrometry system, today announced execution of a lease agreement for a new Corporate Headquarters in Wakefield, MA. The new facility located at 11 Audubon Road doubles the company's capacity and is a result of the increase in demand for RapidFire products and services.
Eli Lilly and Company and AstraZeneca today announced an agreement to co-develop and commercialize AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease.
Eli Lilly and Company has announced that it will be extending its existing patient assistance program, LillyAnswers, through the end of this year to qualifying patients currently participating in the program, to help bridge the gap in coverage for people who need Lilly medicines, but are not yet enrolled in Medicare Part D.
By matching children with rare or life-threatening diseases and modelling potential disease progression, researchers hope to find new routes forward.
› Verified 6 days ago
Entity Name | Hackensack Meridian Health Medical Group - Specialty Care Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215989249 PECOS PAC ID: 9133032519 Enrollment ID: O20031111000524 |
News Archive
As the coronavirus pandemic claims lives and overwhelms health care systems throughout the world, scientists are closely watching several late-stage trials of the antiviral drug remdesivir.
BIOCIUS Life Sciences Inc., developers of the RapidFire® high-throughput mass spectrometry system, today announced execution of a lease agreement for a new Corporate Headquarters in Wakefield, MA. The new facility located at 11 Audubon Road doubles the company's capacity and is a result of the increase in demand for RapidFire products and services.
Eli Lilly and Company and AstraZeneca today announced an agreement to co-develop and commercialize AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease.
Eli Lilly and Company has announced that it will be extending its existing patient assistance program, LillyAnswers, through the end of this year to qualifying patients currently participating in the program, to help bridge the gap in coverage for people who need Lilly medicines, but are not yet enrolled in Medicare Part D.
By matching children with rare or life-threatening diseases and modelling potential disease progression, researchers hope to find new routes forward.
› Verified 6 days ago
Entity Name | Humc Cardiovascular Partners, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417188905 PECOS PAC ID: 6406996503 Enrollment ID: O20091222000199 |
News Archive
As the coronavirus pandemic claims lives and overwhelms health care systems throughout the world, scientists are closely watching several late-stage trials of the antiviral drug remdesivir.
BIOCIUS Life Sciences Inc., developers of the RapidFire® high-throughput mass spectrometry system, today announced execution of a lease agreement for a new Corporate Headquarters in Wakefield, MA. The new facility located at 11 Audubon Road doubles the company's capacity and is a result of the increase in demand for RapidFire products and services.
Eli Lilly and Company and AstraZeneca today announced an agreement to co-develop and commercialize AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease.
Eli Lilly and Company has announced that it will be extending its existing patient assistance program, LillyAnswers, through the end of this year to qualifying patients currently participating in the program, to help bridge the gap in coverage for people who need Lilly medicines, but are not yet enrolled in Medicare Part D.
By matching children with rare or life-threatening diseases and modelling potential disease progression, researchers hope to find new routes forward.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Timothy E Simpson, MD 920 Main Street, Hackensack, NJ 07480 Ph: (201) 342-7733 | Dr Timothy E Simpson, MD 920 Main Street, Hackensack, NJ 07480 Ph: (201) 342-7733 |
News Archive
As the coronavirus pandemic claims lives and overwhelms health care systems throughout the world, scientists are closely watching several late-stage trials of the antiviral drug remdesivir.
BIOCIUS Life Sciences Inc., developers of the RapidFire® high-throughput mass spectrometry system, today announced execution of a lease agreement for a new Corporate Headquarters in Wakefield, MA. The new facility located at 11 Audubon Road doubles the company's capacity and is a result of the increase in demand for RapidFire products and services.
Eli Lilly and Company and AstraZeneca today announced an agreement to co-develop and commercialize AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease.
Eli Lilly and Company has announced that it will be extending its existing patient assistance program, LillyAnswers, through the end of this year to qualifying patients currently participating in the program, to help bridge the gap in coverage for people who need Lilly medicines, but are not yet enrolled in Medicare Part D.
By matching children with rare or life-threatening diseases and modelling potential disease progression, researchers hope to find new routes forward.
› Verified 6 days ago
Dr. Sean Shabbir Sadikot, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 20 Prospect Ave Ste 707, Hackensack, NJ 07601 Phone: 551-996-2211 Fax: 551-996-5727 | |
Mr. Angel J Mulkay, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 493 Essex Avenue, Hackensack, NJ 07601 Phone: 201-996-9244 Fax: 201-601-0995 | |
Dr. Morris Samuel Friedman, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 52 1st St, Hackensack, NJ 07601 Phone: 201-342-0066 Fax: 201-342-0079 | |
Dr. David Serur, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 20 Prospect Ave Ste 406, Hackensack, NJ 07601 Phone: 551-996-2608 Fax: 551-996-0826 | |
Jerome F Levine, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 20 Prospect Ave, Suite 507, Hackensack, NJ 07601 Phone: 201-487-4088 | |
Dr. Noa Biran, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 92 2nd St, Hackensack, NJ 07601 Phone: 551-996-8704 Fax: 551-996-0582 | |
Naresh Chanderi, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 344 Prospect Ave, Hackensack, NJ 07601 Phone: 201-342-4233 Fax: 201-342-4840 |